You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IVA endometrial carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in

Recruiting
  • Recurrent Endometrial Carcinoma
  • +12 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston

Recruiting
  • Malignant Female Reproductive System Neoplasm
  • +24 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Breast Cancer Stage IV Trial in Pittsburgh (Strong Together serious game)

Completed
  • Ovarian Cancer Stage III
  • +12 more
  • Strong Together serious game
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Dec 14, 2021

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
Has Results
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Spatial Transcriptomics of Stage IVa Nasopharyngeal Carcinoma

Not yet recruiting
  • Stage IVA Nasopharyngeal Carcinoma
  • Intensity modulated radiation therapy (IMRT) combined with chemotherapy
  • Nanjing, China
    Jiangsu Cancer Hospital
Jun 21, 2023

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Houston

Recruiting
  • Advanced Endometrial Carcinoma
  • +36 more
  • Glutaminase Inhibitor IPN60090
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 9, 2021

Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I Trial in Beijing (statins (oral atorvastatin calcium tablet

Recruiting
  • Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
  • statins (oral atorvastatin calcium tablet 20mg/ day; Or rosuvastatin 5mg/ day; Or pivastatin 2mg/ day);
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 22, 2023

Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

Recruiting
  • Nasopharyngeal Carcinoma
  • mobile platform or not mobile platform
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Apr 17, 2023

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma Stage I
  • Medroxyprogesterone acetate + Atorvastatin
  • Peking, Beijing, China
    Wang Jianliu
Dec 29, 2022

Endometrial Tumors, Endometrial Tumor Malignant, Endometrial Tumor Malignant Stage I Trial in Beijing (Indication-extended

Recruiting
  • Endometrial Neoplasms
  • +4 more
  • Indication-extended Fertility-sparing Therapy
  • Beijing, Beijing, China
    Peking University People's Hosoital
Jul 12, 2023

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

Not yet recruiting
  • Unresectable Lung Non-Small Cell Carcinoma
  • serplulimab plus chemotherapy as conversion treatment
  • (no location specified)
Apr 27, 2023

Nasopharyngeal Carcinoma Trial in Beijing (Tislelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Beijing, Beijing, China
    National Cancer Center /National Clinical Research Center for Ca
Jul 4, 2022

Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Uterine Corpus Cancer Trial in Bronx (drug,

Terminated
  • Endometrial Serous Adenocarcinoma
  • +6 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma Trial in United States (Intensity-modulated

Recruiting
  • Endometrial Cancer
  • +4 more
  • Intensity-modulated radiation therapy
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Jan 10, 2023

Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

Not yet recruiting
  • Endometrial Carcinoma Stage I
  • Atypical Endometrial Hyperplasia
  • No intervention
  • (no location specified)
Dec 3, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication

Active, not recruiting
  • Cancer Survivor
  • +6 more
  • Communication Intervention
  • +5 more
  • Palo Alto, California
  • +1 more
Oct 24, 2022

Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative Trial in

Completed
  • Activating ALK Gene Mutation Negative
  • +7 more
  • Counseling
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting
  • Metastatic Endometrial Carcinoma
  • +7 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Endometrial Carcinoma, Obesity, EIN Trial in Boston (CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral)

Recruiting
  • Endometrial Carcinoma
  • +4 more
  • CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
  • Boston, Massachusetts
  • +1 more
Aug 2, 2022

Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)

Not yet recruiting
  • Head and Neck Neoplasms
  • TransCon TLR7/8 Agonist
  • +2 more
  • (no location specified)
Aug 4, 2023